Ironwood Pharmaceuticals | IRWD - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Almirall EUR 713.98M 69K 2025-12
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Moderna USD 5.77B 774M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Pacira USD 514.96M 33.01M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12